drugset / Trial / NCT06512233
Heparin Alone vs. Heparin-Aspirin Combo in Free Flap Survival
RandomizedParallel-groupSingle-blindTreatment
Summary
This randomized clinical trial aims to compare the effectiveness of heparin alone versus combination therapy of Heparin- Aspirin in improving free flap survival in patients undergoing reconstructive surgery. Participants will be randomly assigned to receive either heparin or a combination therapy, and the primary outcome measure will be the survival rate of the free flap at various time points post-surgery
Timeline
- Start
- 2025-01
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 75 mg | — |
Indications
No indication recorded.